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23
Although chitosan (CS) has been recognized as one of good materials for 24 colon-specific drug delivery systems, an overcoaitng with an enteric coating polymer on the 25 surface of CS is absolutely necessary because CS is soluble in acidic conditions before 26 reaching colon. In the present study, to improve its stability towards acid, a newly 27 developed CS-laurate (CS-LA) material was evaluated as a coating dispersion for the 28 development of colon-specific drug delivery systems. Two types of CS such as CS250 and 29 CS600 which have different molecular weights were used to prepare CS-LA films by the 30 casting method. The CS250-LA films had smooth surfaces, whereas the surfaces of the 31 CS600-LA films were rough, indicating that the CS250-LA dispersion could form a denser 32 film than CS600-LA. Both of the CS-LA films maintained a constant shape over 22 h in a 33 pH 1.2 HCl/NaCl buffer, where the corresponding CS films rapidly disintegrated. In 34 addition, the CS250-LA film showed specific colon degradability in pH 6.0 phosphate 35 buffered solution containing 1.0% (w/v) β-glucosidase. As the results of tensile strength and 36 elongation at break, both CS-LA films were found to have flexible film properties. Finally, 37 the release of acetaminophen from disks coated with CS250-LA dispersions was 38 significantly suppressed in fluids at pH 1.2 and 6.8, whereas the disks coated with CS 39 solutions rapidly released drug in pH 1.2 fluids. Taken together, this study shows that LA 40 modification could be one of useful approaches to prepare CS films with acid stability and 41 colonic degradability properties without requiring overcoating.
Introduction
51
Interest in the design of oral, colon-specific drug delivery systems has increased 52 considerably during the last decade.
1) The possibility of being able to deliver drug 53 molecules directly to the diseased part of a colon, such as those parts affected by 54 inflammatory bowel diseases (IBD) and colon cancer, would mean that lower doses of the 55 drugs could be used to achieve therapeutic levels. Furthermore, the side effects typically 56 associated with the systemic absorption of drugs from the upper part of the gastrointestinal 57 tract could be reduced or even eliminated entirely by suppressing the release of the drug 58 until the delivery device enters the colon where a triggering mechanism initiates release.
59
Taken together with the fact that the number of IBD patients is currently increasing, 2) there 60 is an obvious need for the development of an effective drug delivery system for the colon. (Tween 80) were purchased from Wako Pure Chemical Industries, Ltd (Osaka, Japan).
131
Chitocoat was provided as a gift from Freund Co., Ltd (Tokyo, Japan). β-Glucosidase from respective saturated solutions were found to be 8.68±0.07 and 9.32±0.10 mg/mL using a 144 drying method, respectively ( Table 1) . Sodium LA (1.5% w/w) was prepared by adding LA to 145 a 0.3% (w/v) solution of NaOH in water. Sodium LA (500 mL) was then added to 1000 mL of LA was ground into a fine powder using a mortar and pestle prior to analysis. The
161
FT-IR spectra of powdered samples of CS, LA and CS-LA were recorded on a DuraSample IR
162
II system (Shimadzu, Kyoto, Japan) at room temperature using an IRPrestige ® -21 (Shimadzu).
163
The FT-IR spectra were recorded under the following conditions: apodization function,
164
Happ-Genzel; range of wavenumber, 500-4000 cm −1 ; and the number of integration times, 20 165 times.
167
Measurement of modification ratio
168
The modification ratio of LA to the amino groups of CS was measured using a Co., Ltd., Tokyo, Japan (Sonifier 250; Branson, Danbury, America) with its adjustable output control set at 6 for 5 min.
192 Table 2 shows the formulation of the dispersion. The diameter of the CS-LA particles in dispersion was determined using a 196 Mastersizer2000 laser diffraction particle size analyzer (Marvern, Worcestershire, UK).
197
Ultrasonic treatment was not conducted during the evaluation process and the agitation speed The polymer films were prepared using the casting method. The polymer dispersion
205
or Chitocoat was poured into a petri dish that had been covered with a Teflon seal (TZ-13;
206
Kawada Co., Tokyo, Japan). Table 3 
Evaluation of the mechanical properties of the polymer films
233
A strip of film (1 cm × 4 cm) was fixed at either end to the attachments of a
234
Tensilon precision universal tester (Orientec, Tokyo, Japan), and the film was then pulled 
5. Drug dissolution test from disks coated with CS and the CS-LA polymer
247
Disks coated with the dispersion were prepared to evaluate the rate of drug release 
Preparation of the disks
251
APAP tablets (300 mg, diameter; 13 mm) were prepared using a hydraulic single 252 punch tableting machine at 100 MPa. The disks were prepared by embedding the tablets into 253 polyvinyl chloride pipes (inner diameter 1.33 cm; height 0.7 cm) and using coins and 254 aluminum foil to cover the reverse side of disks. formed an ion pair with the carboxyl groups of LA (Fig. 2) . The modification ratios of LA to 289 the amino groups of CS250 and CS600 were determined 56.6±3.5 and 68.7±3.5%,
290
respectively by measuring the viscosity ( Table 4 shows the particle size and relative width of particle size (R W ) of the 294 CS-LA dispersion. When CS was used as a control to prepare dispersions, it was dissolved in 295 acetic acid and the dispersion became solution. The CS250-LA dispersion showed a smaller Consideration of the SEM images revealed that the surface of the CS600-LA film 303 was rough, whereas the surface of the CS250-LA films was smooth (Fig. 3) . This difference (Fig. 4A, closed bar) . The CS600 315 films prepared using dispersions containing 0.5, 1.0 and 1.5% glycerin disintegrated in 9.0, 316 14.0 and 17.0 h, respectively (Fig. 4B, closed bar) . The fact that the CS films prepared using 317 dispersions containing 1.5% glycerin could maintain their form for 17 h was attributed to the 318 thick nature of the films (about 100 μm). In contrast, CS250-LA films prepared using 319 dispersions containing 0.5, 1.0 and 1.5% glycerin showed longer disintegration times of 22.0, 320 39.3 and 42.3 h, respectively (Fig. 4A, open bar) . CS600-LA films prepared using 321 dispersions containing 0.5, 1.0 and 1.5% glycerin also showed longer disintegration times of 322 47.0, 59.0 and 62.7 h, respectively (Fig. 4B, open bar) . These results demonstrated that the disintegration times of the CS-LA films were more than twice as long as those of the CS films.
324
Based on these results, it was obvious that the derivatization of CS led to greater stability 325 under gastric condition. In fact, even though the coating thickness of these formulations was the CS250 films were disintegrated to some extent in the absence of β-glucosidase (Fig. 5A,   336 closed bar), they all completely disintegrated in the presence of β-glucosidase (Fig. 5A, open   337 bar). The CS600 films were also disintegrated to some extent in the absence β-glucosidase 338 (Fig. 5B) . However, a significant weight loss was only observed for the CS600 films 339 containing 0.5% glycerin in the presence of β-glucosidase (Fig. 5B) . It has been reported that 340 lower molecular weight CS is more easily degraded than higher molecular weight CS. 14) As
341
for CS-LA films, all of the CS250-LA films showed high weight losses in the presence of 1.0 and 1.5% glycerin, respectively) (Fig. 5C, open bar) , whereas the weight losses in the 344 absence of β-glucosidase were much lower (i.e., 20.9, 39.0 and 49.4% with 0.5, 1.0 and 1.5% 345 glycerin, respectively) (Fig. 5C, closed bar) . In contrast, only the CS600-LA containing 0.5% 346 glycerin showed a significant weight loss (Fig.5D ). This result was attributed to the 347 CS250-LA material being more easily recognized by the β-glucosidase than CS600-LA 
